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ABSTRACT
Previous data suggest that a polymorphism at the serotonin (5-HT) transporter gene
(5-HTTLPR) may influence stress resilience and stress-related depression symptoms
due to interactions between brain 5-HT dysfunction and stress exposure. Although
attentional bias for emotional information has been reliably observed in depression,
the interaction between 5-HTTLPR, brain 5-HT vulnerability and acute stress on
affective information processing has not yet been investigated. This study examines
the effects of tryptophan augmentation (indicating 5-HT manipulation) on inhibition
of negative emotional information under stress in mainly female S’/S’ versus L’/L’
allele carriers.
Fifteen female homozygotic short-allele 5-HTTLPR (S’/S’= S/S, S/LG, LG/LG) and 13
female homozygotic long-allele 5-HTTLPR (L’/L’= LA/LA)  subjects  were  tested  for
mood and inhibition of emotional information in a double-blind placebo-controlled
design before and after stress exposure following tryptophan manipulation.
Stress exposure significantly impaired inhibition of negative affective information
only in S’/S’ carriers, whereas L’/L’ carriers even showed increased inhibition of
negative information.
The S’/S’ allele 5-HTTLPR genotype increases cognitive-attentional bias for negative
emotional information under acute stress. Since this bias is an important component
of depression, this may be a mediating mechanism making S’/S’-allele carriers more
vulnerability for stress-induced depression symptoms. Moreover, current data suggest
that L’/L’-allele genotypes are more resilient, even increasing cognitive emotional
(inhibitory) control after stress.
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INTRODUCTION
The identification of biological vulnerability factors for depression is an
important challenge facing biological psychiatry today. Among the various
biochemical processes involved, brain serotonin (5-HT) dysfunction appears to be a
meaningful risk factor (Maes and Meltzer, 1995; Van Praag, 2004). 5-HT dysfunction
manifests in depressed patients as lowered brain tryptophan concentrations (e.g. Agren
and Reibring, 1994; Maes et al, 1990); impaired 5-HT synthesis, release, reuptake, or
metabolism (e.g. Maes and Meltzer, 1995; Malison et al, 1998; van Praag et al, 1970); or
5-HT receptor disturbances (e.g. Cowen et al, 1994; Sargent et  al, 2000), whereas
antidepressant drugs generally act by improving brain 5-HT function (Delgado et al,
1990; Delgado et al, 1993; Maes and Meltzer, 1995).
5-HT dysfunction in depression is promoted by a genetic vulnerability
involving a polymorphism in the 5-HT transporter-linked promoter region (5-
HTTLPR). This region encodes the 5-HT transporter protein (5-HTT) that controls 5-
HT reuptake and function and which is the main target mechanism for antidepressant
drugs (Serretti et  al, 2007). The short-allele (S) variant of 5-HTTLPR is associated
with fewer 5-HTT binding sites compared to the long-allele (L) variant (Heils et al,
1996; Mann et al, 2000) and is involved in 5-HT dysfunction during depression (Jans
et al, 2007). Recently, the presence of an A>G single nucleotide polymorphism has
been  identified  in  the  L  allele,  rendering  an  Lg  variant  (as  opposed  to  La)  that  is
functionally equivalent to the S-allele (Hu et al, 2005; Wendland et  al, 2006).
However, 5-HT dysfunction in depression is also promoted by stress due to
interactions between 5-HT and the hypothalamus-pituitary-adrenal (HPA) system (Firk
and Markus, 2007; Van Praag, 2004). Hence, depression is often preceded by stress
(Van Praag, 2004), and there is a positive association between the number of copies of
the S-allele 5-HTTLPR and self-reports of past depressive responses to stressful events
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(Caspi et al, 2003; Jacobs et al, 2006; Wilhelm et  al, 2006). However, attempts to
replicate these findings have yielded mixed results (Risch et al, 2009).
Despite the suggestion from previous studies that stressful events might
promote depression symptoms mostly in homozygous S-allele compared to
homozygous L-allele 5-HTTLPR carriers, actual interactions between genetic 5-HT
vulnerability, stress exposure and depression have barely been investigated. A recent
experimental study reveals evidence for enhanced HPA stress-responses exclusively
in homozygous S-allele 5-HTTLPR carriers (Gotlib et al, 2008), but this experiment
did not include the measurement of depression-specific cognitive-affective changes or
of brain 5-HT vulnerability.
Depression specific changes can be adequately measured by negative affective
priming (NAP) tasks that measure attentional bias for emotional information
(Goeleven et  al, 2006; Joormann, 2004). Hence, attentional bias for negative
information is a hallmark feature of MDD (see (Scher C, 2005) which relates to
impaired cognitive inhibition towards negative emotional material (Goeleven et  al,
2006); (Gotlib, 2005); (De Raedt, 2010). In support, 5-HT is implicated in decreased
attentional control over negative stimuli by modulating prefrontal-amygdala
connectivity (see (Cools, 2007), and S/S show enhanced emotional amygdala
responses {Hariri, 2006} and impaired disengagement to emotional information
(Beevers, 2009).
Brain 5-HT vulnerability relates to an enhanced sensitivity to alterations in the
5-HT system (Jans et al, 2007). This can be measured by acute tryptophan depletion
(Biggio et al, 1974; Carpenter et al, 1998; Nishizawa et  al, 1997; Williams et  al,
1999) that has been found to increase depression symptoms in individuals at risk for
depression (Ruhe et al, 2007) including homozygous S-allele 5-HTTLPR carriers
(Neumeister et  al, 2002); (Neumeister et  al, 2006). However, because S/S-allele
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carriers may exhibit altered 5-HT sensitization to compensate lower 5-HTT
expression (David et  al, 2005); (Moore P, 2000), tryptophan challenge may be an
alternative method to reveal 5-HT vulnerability associated with 5-HTTLPR. In
support, tryptophan administration improved mood in S/S not L/L-allele carriers
(Markus, 2009).
The current study is the first to investigate the interaction between acute stress,
5-HTTLPR and 5-HT vulnerability on the inhibition of negative emotional
information. Based on previous assumptions, it is hypothesized that stress reduces the
inhibition  of  negative  information  in  S/S  not  L/L-allele  carriers  and  that  TRP
administration reduces this effect only in S/S-allele carriers.
METHODS
Participants
Students from Maastricht University completed a questionnaire package concerning
general information (health, personal or family history of medical or psychiatric
complaints, smoking and drinking habits, caffeine consumption, weight and height, use
of psychoactive drugs) and concerning relevant symptoms and psychopathology (Beck
Depression Inventory [BDI], Inventory of College Students’ recent life experiences
[ICSRLE], Inadequacy/neuroticism Scale of the Dutch Personality Inventory [IN] and
the Social Complaints List [SCL]). Exclusion criteria were health or medical
complaints; personal or family history of psychiatric illness; history of medical illness;
medication use; metabolic-, hormonal- or intestinal diseases; irregular diet; deviant
eating habits or excessive alcohol or drug use. Following this first selection, 90
participants attended a buccal sample extraction session to genotype for 5-HTTLPR
(resulting in 26% S/S, 46% S/L and 28% L/L). Since brain 5-HT vulnerabilities for
stress are mainly found in homozygotes S compared to homosygotes L allele carriers
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(e.g. (Neumeister et al, 2002); (Caspi et al, 2003); (Wilhelm et al, 2006); (Zalsman et
al, 2006), only homozygous S-allele (S/S, S/LG, LG/LG;  classified  as  S’/S’)  and
homozygous L-allele (LA/LA;  classified  as  L’/L’)  were  then  invited  for  a  psychiatric
structured interview (MINI: (Sheehan et  al, 1994) to double-check exclusion
compliance and to receive information about the experiment. After invitation, before
the psychiatric interview, a number of 8 S’/S’ and 12 L’/L’ subjects refrained from
further participation due to shortage of time or other non-specified reasons.
Fifteen S’/S’ and 13 L’/L’ female participants completed the experiment. Both
groups included Caucasian participants with European (mainly Dutch) background.
They all revealed normal body-mass indexes (BMI in kg/m2 between 20-25; mean
22±2), were non-smokers and were requested not to use alcohol or any kind of drugs
24 hours prior to and during the study. Both groups did not differ in age, BMI and
additional relevant symptoms. The study was approved by the Medical Ethics
Committee of the Academic Hospital Maastricht (CTCM azM; Maastricht; The
Netherlands) and the procedures followed were in accordance with the Helsinki
Declaration of 1975 as revised in 1983. All subjects gave their written informed
consent and were paid for participation.
Design and procedure
A placebo-controlled, double-blind, crossover design was used. During two sessions,
subjects were monitored for negative affective priming (NAP) before and after stress
exposure following intake of tryptophan (TRP) or placebo (PLC). The order of
presentation of the treatment conditions was counterbalanced within groups; both
sessions were separated by one week. All subjects were tested in the mid-late follicular
phase of their menstrual cycle or when actually taking oral contraceptives. An
illustration of the design is given in Figure 1.
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-------------------- FIGURE 1 --------------------
All  participants  fasted  overnight;  except  for  water  or  tea  without  sugar.  On  each
experimental day, three participants arrived at 08:00 a.m., 09:00 a.m. and 10:00 a.m.,
respectively. Capsules were consumed 1 hour before arrival. After arrival and a
subsequent 15min rest period, mood and NAP was assessed. Then, participants were
exposed to a stress-inducing procedure followed by a second mood and NAP measure.
Stress exposure
Subjects were placed in front of a camera for 20min while completing 2-min serial
subtraction sessions and cold-pressor exposures. At unpredictable occasions, they were
signaled to start at a certain number and count backwards by seven as quickly as
possible. If they made a mistake, they were interrupted by the experimenter and had to
start over. In addition, at unpredictable occasions while continuing counting, they had
to place their non-preferred hand on a 1.5 0C cold plate for as long as possible (with a
maximum of 2 min). For cold-pressor exposure, a cooler device was used composed of
a copperplate surface (150x230mm) that was thermoelectrically cooled at a constant
level by way of Peltier (TEC) devices. Backward counting was initiated at four
different unpredictable 180±30sec time intervals using different numbers (400, 425, 530
or 840) that were counterbalanced within-subjects. Cold-pressor signals appeared at six
unpredictable 120±60sec time intervals either during (85%) or between (15%) counting
sessions.
Tryptophan challenge
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To increase plasma tryptophan, 0.8g tryptophan (TRP) as compared to 0.8g placebo
(Cellulose) capsules were used. Comparable intake of tryptophan has been shown to
increase plasma TRP availability (TRP/LNAA ratio) with 190% 60-90min after intake
(Markus et al, 2008). Capsules were identical and subjects were instructed to swallow
them whole with water.
Positive and Negative Affect Scale (PANAS).
The PANAS (Watson et  al, 1988) consists of two 10 items mood scales, a positive
mood scale and a negative mood scale. These items are randomly presented and
participants  have  to  respond on  a  scale  ranging  from 1  (totally  disagree)  to  5  (totally
agree).
Negative Affective Priming (NAP)
The NAP task included (5x5.5cm) colored pictures of positive (n=33), negative
(n=33) or neutral (n=22) faces that were selected from the Karolinska Emotional
Directed Faces database (Lundqvist, 1998) and based on prior validation (Goeleven et
al, 2006). Pictures were divided into eight lists (based on stimulus type) of 11
randomly chosen pictures sharing the same valence: one negative and one positive
prime target list, one negative and one positive prime distracter list, one negative and
one positive probe target list and two neutral probe distracter lists. Pictures were
indicated as target or distracter by a black or grey frame. Participants were instructed
to evaluate the valence of the target picture –indicated by the colour of the frame– as
accurately as possible by a response key while ignoring the distracter picture. Each
trial started with a fixation cross (for 1000 ms) after which two emotional faces
appeared in the upper and the lower half of the screen (one surrounded by a grey
frame and one by a black frame) until responding (see Figure 2).
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-------------------- FIGURE 2 --------------------
After training (including 32 trials), a sequence of 256 test trials (separated by a 1000
ms blank screen) followed that were divided into eight blocks of 16 prime and probe
trials. The response cue (grey or black frame) and key assignment was
counterbalanced between subjects and the spatial position of the target and the
distracter –as well as sequence of congruent and incongruent prime-probe trials- were
randomly assigned from trial to trial. Reaction time (RT) to the probe trials for both
the positive and negative trials were reordered (RT below 300ms and above 2000ms
were excluded, see (Goeleven et al, 2006) and NAP scores were calculated by
subtracting RT to control trials from RT to experimental trials.
Buccal cells for tri-allelic 5-HTTLPR polymorphism
Buccal cell samples for 5-HTTLPR genotype determination were obtained using sterile
swabs (Omni Swabs, Whatman, ’s Hertogenbosch, The Netherlands). Genomic DNA
was isolated by QIamp DNA Mini Kits from Qiagen (Westburg, Leusden, The
Netherlands) and 5-HTTLPR genotyping was performed using the polymerase chain
reaction (PCR) protocol according to Glatz et al. (2003). In compliance with previous
work (e.g. Neumeister et  al, 2006; Walderhaug et  al, 2007; Zalsman et al, 2006), tri-
allelic variants were reclassified into a bi-allelic model as follows: S/S, S/LG and LG/LG
were classified as S’/S’ and LA/LA as L’/L’.
Statistical analysis
Data were first examined for accuracy of data-entry, missing values and normal
distributions. Hardy-Weinberg equilibrium was determined on the original 5-HTTLPR
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data-base (N=90) using X² tests, revealing that the genotype frequencies of S’/S’
(N=24), S/L (N=40) and L’/L’ (N=26) did not depart from Hardy-Weinberg
equilibrium (X2(1)=1.45; p=0.23). Data was analyzed by means of repeated measures
anova (GLM: SPSS 12.0 for Windows) with one between-subjects factor Genotype
(S’/S’ vs L’/L’) and two within-subjects factors Treatment (TRP vs  PLC)  and Stress
(pre-stress  vs.  post-stress)  on  mood  (PANAS)  and  NAP.  Regarding  NAP,  repeated
measures were conducted on difference reaction time (RT) scores between control and
experimental probe trials; separately for the positive and negative trials. Although we
counterbalanced for the order of treatment, Order of Treatment was preliminary taken as
a between-subjects factor. Because Order of Treatment did not contribute to any of the
scores, final analyses were performed with only Genotype as between-subjects factor. All
statistics are evaluated at a two-tailed significance level of 5%. Data are reported as
means ± SD.
RESULTS
PANAS
Repeated measure analyses were conducted on the PANAS scores for positive and
negative mood with Genotype (S’/S’ vs L’/L’) as between-subjects factor and
Treatment (TRP vs PLC) and Stress (pre-stress vs. post-stress) as within-subjects
factors. Analysis revealed an effect of Stress on  positive  feelings  [F(1,26)=13.49,
p=0.001; Power=.95] and negative feelings [F(1,26)=15.52, p=0.001; Power= .94];
indicating a reduction in positive feelings post-stress (2±0.7) compared to pre-stress
(2.6±0.7) and an increase in negative feelings post-stress (1.3±0.4) compared to pre-
stress (1.0±0.2). Regarding negative mood, analysis revealed an interaction of
Treatment x Genotype [F(1,26)=6.01, p= 0.02; Power= .70], Treatment x Stress
[F(1,26)=4.58, p= 0.042; Power=.60] and a marginally three-way interaction of
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Treatment x Stress x Genotype [F(1,26)=4.2, p= 0.041; Power=.50]. As shown in Fig
3, S’/S’ reported a modest increase in negative feelings post-stress (1.6±0.9) compared
to  pre-stress  (1.0±0.12)  after  PLC  that  was  absent  after  TRP  (1.1±0.3  post-stress
compared to 1.1±0.2 pre-stress).
-------------------- FIG 3 --------------------
NAP: Negative Affective Priming
Repeated measure analyses were conducted on the NAP scores for positive and
negative trials with Genotype (S’/S’ vs L’/L’) as between-subjects factor and
Treatment (TRP vs PLC) and Stress (pre-stress vs. post-stress) as within-subjects
factors. Analysis revealed an interaction of Stress x Genotype [F(1,26)=16.84, p
<0.001; Power= .95] for the negative trials; indicating an effect of stress exposure on
inhibition of negative emotional information depending on 5-HTTLPR. As illustrated
in Figure 4, stress exposure significantly impaired inhibition of negative emotional
information in S’/S’ (P<0.0001), whereas in L’/L’ inhibition of negative information
improve (higher NAP) by stress exposure (P=0.027).
-------------------- FIG 4 --------------------
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DISCUSSION
The aim of the present study was to explore whether the S’/S’ compared to the L’/L’-
allele variant of the 5-HTTLPR increases the negative effects of stress exposure on
the inhibition of affective information. Assuming 5-HTergic vulnerability in carriers
of the low expressing 5-HTTLPR, S’/S’ allele carriers were also expected to be less
affected by stress following TRP compared to PLC. Results revealed that stress
exposure significantly reduced mood and that only in S’/S’-allele carriers did stress
impair the successful inhibition of negative affective information.
Stress and NAP
To induce acute stress, subjects completed serial subtraction sessions in combination
with frequent cold-pressor exposures. Both the cold-pressor exposures (Isowa et  al,
2005) and counting tasks (Dickerson and Kemeny, 2004) have been shown to be
sufficient to induce stress; repeated exposures given in a variable and unpredictable
manner have induced even more severe stress responses (Markus, 2007). In addition,
the stress procedure in the current study was sufficient to induce negative mood
responses.
In line with our expectation, exposure to the stress procedure increased the facilitation
of negative information processing only in S’/S’-allele carriers. Hence, exclusively in
S’/S’, acute stress speeded up recognition for negative facial expressions during
experimental NAP conditions (responding to negative probe targets that are preceded
by prime distracters with the same negative valence) compared to control conditions
(responding to negative probe targets that are preceded by prime distracters with an
opposite valence). Because this reduced NAP effect represents an impaired inhibitory
function towards negative affective information (Joormann, 2004); (Goeleven et  al,
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2006), the current findings suggest that S’/S’-allele carriers are more susceptible to
the deteriorating effects of stress exposure on the successful inhibition of negative
information. In contrast, L’/L’-allele carriers not only did not show these
vulnerabilities, they were more successful at inhibiting negative information under
stress  (indicating  that  this  variant  could  be  a  marker  of  resilience  against  the
detrimental effects of stress).
The current ‘boosting’ effect of acute stress on the facilitation of negative information
processing in S’/S’-allele carriers complies with recent findings that homozygous S’-
allele  are  most  susceptible  to  the  negative  affective  (Firk  ,  2009)  and  hormonal
(Gotlib et al, 2008) effects of stress exposure and to the depressogenic effects of life
events (Caspi et al, 2003); (Uher R, 2008). In addition, the current study elaborates on
previous findings by showing that the enhanced vulnerability in S’/S’-allele carriers
for stress-related depression may be mediated by a stress-induced impairment in the
ability to inhibit negative information. This also complies with findings from imaging
studies showing that S-allele carriers exhibit enhanced amygdala responses to
negative facial expressions (Pezawas et al, 2005); (Dannlowski et al, 2008). This
result has been attributed to a reduced amygdala-to-prefrontal-cortex connectivity (a
reduced inhibition of the amygdala) that is also observed in depression (Siegle et al,
2007).
The current stress-induced increase in negative information processing in S’/S’-allele
carriers can be explained by the mood-congruent hypothesis that negative affective
interruption facilitates continued processing of negative information. In addition, the
previously demonstrated depressogenic effects of life events on S/S-allele carriers
(Caspi et al, 2003); (Uher R, 2008) may be moderated by a stress-induced increase in
attentional bias allowing for maintained attention on negative material. Thus, in S’/S’-
allele carriers, stress may reduce the successful inhibition of distracting negative
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stimuli. In fact, this stress-induced disturbed inhibitory functioning is thought to be a
core factor that is related to the previously observed difficulties in depressed patients
to disengage attention away from negative information (Koster et  al, 2005). In
addition and comparable both with our current findings in healthy S’/S’-allele carriers
and with the assumption that S’/S’-allele carriers are more prone to develop
depression, depressed subjects have also been shown to exhibit a reduced ability to
inhibit negative information during a NAP task (Goeleven et  al, 2006); (Leyman, in
press).
To reveal whether S’/S’ are more susceptible to the effects of stress due to brain 5-HT
vulnerability, a TRP challenge was used in the current study. Based on previous
studies reporting a 5-HT vulnerability to the mood-lowering effects of ATD in S’/S’-
allele carriers (Neumeister et al, 2006; Neumeister et al, 2002; Roiser et al, 2006), it
was hypothesized that TRP may reduce the negative stress effects. The current
findings however did not reveal significant TRP effects on NAP and only marginally
(reducing) effects on negative mood in S’/S’ carriers.
Limitations
One point that deserves special attention is the relatively small sample size of the S’/S’
and L/L groups. Even though the current findings reveal powerful genotype x stress
interaction effects on NAP, the sample sizes might have been too small to also detect
TRP  x  stress  interactions  on  NAP.  Another  point  of  attention  is  that  the  current
findings only included female subjects. It therefore remains necessary to conduct a
comparable experiment in a comparable sample of male participants.
Conclusion
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The current findings reveal that stress exposure in female S’/S’ not L’/L’-allele
carriers reduces inhibitory functioning for negative information. Because S’/S’
carriers are found to be vulnerable to the negative depressogenic effects of stress, the
current data is in line with the assumption that a stress-by-depression interaction in
S’/S’-allele carriers may be promoted by a stress-induced facilitation of negative
emotional information.
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FIGURE LEGENDS
Figure 1. Schematic overview of the study design.
Figure 2. Negative Affective Priming Design
Figure 3. S’/S’ reported an increase in negative feelings post-stress compared to pre-
stress (1.0±0.13) after PLC that was prevented after TRP (1.2±0.3 post-stress
compared to 1.1±0.2 pre-stress).
Figure 4 Acute stress exposure significantly impaired inhibition of negative emotional
information (reduced NAP) only in S’/S’ genotypes (P<0.0001), whereas in L’/L’
genotypes inhibition of negative information improved (higher NAP) by stress
exposure (P=0.025).
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